Remgro, the investment holding company chaired by Johann Rupert, says it is looking for a 50-50 partnership in a possible buyout and delisting of its largest asset, Mediclinic.

At investor-day presentation on Tuesday, CEO Jannie Durand fielded a spate of questions over Mediclinic, and while he said the information he could provide was limited, the group was looking for an equal partnership — implying that Remgro is looking to take its stake in Mediclinic to 50% from its current 44.6%...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.